Padmanabh P. Bhatt Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

SUPN Quotes by TradingView

Padmanabh P. Bhatt is Sr. VP of IP, CSO of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 12,704 shares of SUPN, which is worth approximately $406,909. The most recent transaction as insider was on Feb 26, 2024, when has been sold 5,000 shares (Common Stock) at a price of $30.21 per share, resulting in proceeds of $151,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.7K
31.25% 3M change
48.24% 12M change
Total Value Held $406,909

Padmanabh P. Bhatt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2024
SELL
Open market or private sale
$151,050 $30.21 p/Share
5,000 Reduced 36.85%
8,570 Common Stock
Feb 26 2024
BUY
Exercise of conversion of derivative security
$45,650 $9.13 p/Share
5,000 Added 26.93%
13,570 Common Stock
Feb 23 2024
SELL
Payment of exercise price or tax liability
$18,540 $29.06 p/Share
638 Reduced 6.93%
8,570 Common Stock
Feb 23 2024
BUY
Grant, award, or other acquisition
-
1,250 Added 11.95%
9,208 Common Stock
Feb 22 2024
SELL
Payment of exercise price or tax liability
$10,393 $27.94 p/Share
372 Reduced 4.47%
7,958 Common Stock
Feb 22 2024
BUY
Grant, award, or other acquisition
-
750 Added 8.26%
8,330 Common Stock
Sep 07 2023
SELL
Payment of exercise price or tax liability
$37,942 $32.1 p/Share
1,182 Reduced 14.16%
7,165 Common Stock
Sep 07 2023
BUY
Exercise of conversion of derivative security
-
2,500 Added 23.05%
8,347 Common Stock
May 11 2023
BUY
Exercise of conversion of derivative security
-
750 Added 12.01%
5,497 Common Stock
Apr 11 2023
BUY
Grant, award, or other acquisition
-
1,500 Added 24.01%
4,747 Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
750 Added 18.76%
3,247 Common Stock
Jan 17 2023
SELL
Open market or private sale
$192,653 $39.92 p/Share
4,826 Reduced 74.59%
1,644 Common Stock
Jan 17 2023
BUY
Exercise of conversion of derivative security
$44,061 $9.13 p/Share
4,826 Added 42.72%
6,470 Common Stock
Jan 06 2023
SELL
Open market or private sale
$6,942 $39.9 p/Share
174 Reduced 9.57%
1,644 Common Stock
Jan 06 2023
BUY
Exercise of conversion of derivative security
$1,588 $9.13 p/Share
174 Added 8.73%
1,818 Common Stock
Dec 01 2022
SELL
Open market or private sale
$187,399 $37.48 p/Share
5,000 Reduced 75.26%
1,644 Common Stock
Dec 01 2022
BUY
Exercise of conversion of derivative security
$45,650 $9.13 p/Share
5,000 Added 42.94%
6,644 Common Stock
Nov 11 2022
SELL
Open market or private sale
$237,660 $34.95 p/Share
6,800 Reduced 80.53%
1,644 Common Stock
Nov 11 2022
BUY
Exercise of conversion of derivative security
$62,832 $9.24 p/Share
6,800 Added 44.61%
8,444 Common Stock
Nov 09 2022
SELL
Open market or private sale
$24,479 $34.97 p/Share
700 Reduced 29.86%
1,644 Common Stock
Nov 09 2022
BUY
Exercise of conversion of derivative security
$6,468 $9.24 p/Share
700 Added 23.0%
2,344 Common Stock
Jul 15 2022
BUY
Grant, award, or other acquisition
-
750 Added 31.33%
1,644 Common Stock
PPB

Padmanabh P. Bhatt

Sr. VP of IP, CSO
Rockville, MD

Track Institutional and Insider Activities on SUPN

Follow SUPERNUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SUPN